On May 20, 2024, Moores Cancer Center hosted its first Clinical Trials Patient Appreciation Day. During the event, three patients—and their treating physicians—spoke about their personal experiences as participants in clinical trials at Moores. …Continue Reading Moores Clinical Trials Patient Appreciation Day
Moores Cancer Center Member Dr. Corina Antal is leading groundbreaking research, recently funded by a V Foundation Grant, to uncover new therapeutic treatments for pancreatic cancer. In this Q&A, Dr. Antal describes the focus, importance, and impact of her research. …Continue Reading New Avenues in Pancreatic Cancer Treatment: A Q&A with Corina Antal, PhD
On June 5, 2024, Moores Cancer Center welcomed Adam Yala, PhD, who presented “Machine Learning for Personalized Cancer Care.” In a rapidly evolving healthcare landscape, especially with respect to technology and artificial intelligence, this topic is of particular importance for both Moores and UC San Diego Health, given the promise of machine learning for cancer detection. …Continue Reading Machine Learning for Personalized Cancer Care: Distinguished Scientist Director’s Seminar Series
We are delighted to announce the appointment of Ramez N. Eskander, MD as the CTO Director at UC San Diego Health and Moores Cancer Center. Dr. Eskander, who advances oncology through innovative gynecology oncology research, will lead CTO into a new era of discovery and patient care….Continue Reading Ramez N. Eskander, MD Appointed Clinical Trials Office (CTO) Director for Oncology at UC San Diego Health Oncology and Moores Cancer Center
Dr. Kate Gold has been appointed as Chief of the Division of Hematology and Oncology at Moores Cancer Center. Dr. Gold was selected as interim Chief for the division, after an internal search earlier this year. …Continue Reading Kathryn A. Gold, MD Appointed Chief of the Division of Hematology and Oncology at the UC San Diego Moores Cancer Center
SAN DIEGO, November 13, 2023 – The nation’s largest non-government, non-profit funder of cancer researcher, ACS, has awarded Moores Member, J. Silvio Gutkind, Ph.D., the ACS Research Professor Award. Dr. Gutkind is one of two recipients of this prestigious award for investigators who have made ground-breaking contributions in cancer research. This award recognizes exceptional track records…Continue Reading J. Silvio Gutkind, PhD Receives American Cancer Society (ACS) Research Professor Award
Sunil J. Advani, MD, as the new co-leader of the Moores Cancer Center (MCC) Cancer Biology and Signaling (CBS) research program, will join current co-leader Jing Yang at the helm of the program….Continue Reading Sunil J. Advani, MD, Appointed Co-Leader of the Cancer Biology and Signaling Program at Moores Cancer Center
Leslie A. Crews, PhD, Assistant Professor of Medicine, Division of Regenerative Medicine at UC San Diego, as the new Co-Leader of the MCC Hematologic Malignancies Program, joining current Co-Leader, Thomas Kipps, MD, PhD, Professor of Medicine, Evelyn and Edwin Tasch Chair in Cancer Research….Continue Reading Leslie A. Crews, PhD, Appointed Co-Leader of the Hematologic Malignancies Research Program at Moores Cancer Center
Jason Sicklick, MD, FACS has been appointed as the new Co-Leader of the Moores Cancer Center (MCC), Structural and Functional Genomics (SFG) Research Program, and will join current Co-Leader, Jill Mesirov, PhD at the helm of the program….Continue Reading Jason Sicklick, MD, FACS Appointed Co-Leader of the Structural and Functional Genomics Research Program at Moores Cancer Center
Moores Cancer Center Member and Vice Chancellor for Health Sciences at UC San Diego, John M. Carethers, M.D., has been elected a Member of the American Association for Cancer Research (AACR), Board of Directors for the 2023–2026 term….Continue Reading John M. Carethers, MD, Elected to AACR Board of Directors